The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Driven by lessons from the pandemic and a reliance on imports -- more than $2.16 billion in packaged medicines in 2023, most ...

President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

Jerry Keybl, senior vice-president, Biopharma Products and Strategy, Avantor, discusses innovations in biomanufacturing and ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

President Trump plans tariffs of up to 250% on imported drugs to boost U.S. pharmaceutical manufacturing. While aimed at reshoring production, the proposal sparks industry concerns over rising costs ...

President Donald Trump plans to start with a “small tariff” on pharmaceutical imports before ramping duties up to 250% within ...

Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...